Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/15/2003US20030092614 Protein isoform related to sideroflexin 1, named ADPI-41, Alzheimer's disease-Associated Protein Isoform (ADPI); vectors, host cells, antibodies, vaccines; use in the diagnosis, screening, treatment and prophylaxis of AD
05/15/2003US20030092613 Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptides
05/15/2003US20030092612 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
05/15/2003US20030092611 Nucleic acids, proteins, and antibodies
05/15/2003US20030092609 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others
05/15/2003US20030092607 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability
05/15/2003US20030092606 Formulations for amylin agonist peptides
05/15/2003US20030092604 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/15/2003US20030092603 Identification of specific modulators of bone formation
05/15/2003US20030092180 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
05/15/2003US20030092157 Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels
05/15/2003US20030092156 Purified protein for use in the treatment and diagnosis of cancer
05/15/2003US20030092154 Novel molecules
05/15/2003US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092133 Interleukins-21 and 22
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092129 Nervous system polypeptide for use in the treatment of nervous system disorders
05/15/2003US20030092127 Nucleotide sequences coding polypeptides for use in the treatment of asthma, parkinson's, heart, hypotensive and urogenital disorders
05/15/2003US20030092126 Fragments of leptin (ob protein)
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092119 Nuclear hormone receptors
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092112 Novel nucleic acids and polypeptides
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092109 Composition for use in the prevention of diarrhea and the diagnosis of malaria
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092102 Nucleic acids, proteins, and antibodies
05/15/2003US20030092101 Human tumor necrosis factor receptors TR13 and TR14
05/15/2003US20030092080 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
05/15/2003US20030092079 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions
05/15/2003US20030092077 Chemotactic peptide for use in the diagnosis and treatment of reproductive disorders
05/15/2003US20030092063 Nucleotide sequences coding polypeptide for use in the treatment of cancer and diabetes
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092038 Genes for Niemann-Pick type C disease
05/15/2003US20030092037 Elk1 phosphorylation related gene
05/15/2003US20030092035 Nucleotide sequences coding polypeptide for use in the treatment of pain
05/15/2003US20030092030 Wit 3.0, a novel gene to control soft tissue wound healing
05/15/2003US20030092025 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment, prevention of tumor disorders
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030092004 Excitatory glycine receptors and methods
05/15/2003US20030092003 Nucleic acid sensor molecule which modulates expression of amyloid precursor proteins cleaving enzyme; for use in the treatment of nervous system disorders
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030091999 Nucleotide sequences coding complex for use in treatment of cancer and viral disease
05/15/2003US20030091996 Apoptin-associating protein
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091975 Multiple determinants for metabolic phenotypes
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091652 Hydrolysis in aquous solution using proteolytic enzyme
05/15/2003US20030091649 ICAM-1 formulation having controlled-size microparticles
05/15/2003US20030091643 Amorphous mixture of acid sensitive drug and addition polymer; chemical resistance, stability
05/15/2003US20030091637 Drug core with polymeric overcoating
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091606 Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091587 Bactericides, fungicides, viricides
05/15/2003US20030091586 Fish immunoglobulin
05/15/2003US20030091583 Use of mia in immunotheraphy
05/15/2003US20030091582 Autoimmune diseases; antitumor agents; antiallergens
05/15/2003US20030091581 Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
05/15/2003US20030091580 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/15/2003US20030091576 Therapy, prevention vascular system diseases; administering fusion protein; cardiovascular disorders
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091568 Inhibitors for the formation of soluble human CD23
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091565 Binding polypeptides and methods based thereon
05/15/2003US20030091564 Methods of treating an undesired immune response by blocking the binding 0f cd40 ligand to cd40
05/15/2003US20030091563 Novel GPCR-proteins and nucleic acids encoding same
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091559 Biocompatibility; liquid phase
05/15/2003US20030091558 Storage-stable fibrinogen solutions
05/15/2003US20030091557 Methods and compositions for modulating ACE-2 activity
05/15/2003US20030091556 Methods of inhibiting tumor growth and angiogenesis with anastellin
05/15/2003US20030091555 Sterilizing food poison bacteria using ethylenediamine, or salt thereof as chelate compound
05/15/2003US20030091554 Central nervous system disorders
05/15/2003US20030091553 Use of histamine to treat liver disease
05/15/2003US20030091551 Tyrosone kinase as insulin receptor; antidiabetic agents
05/15/2003US20030091548 Gene therapy for the prevention of autoimmune disease
05/15/2003US20030091547 Antiischemic agents; administering endothelial cells, bone marrow culture
05/15/2003US20030091546 Surgery removal of cell; transformation, transcription; reinsertion
05/15/2003US20030091545 Insoluble collagen matrix containing cells, microspheresc and promoters
05/15/2003US20030091544 Gene expression
05/15/2003US20030091539 Use of DF3/MUC1 regulated expression in gene therapy
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091536 In vivo treatment of joint disease using interleukin-1
05/15/2003US20030091534 Adenoviral vectors having a protein IX deletion
05/15/2003US20030091533 Regulation of mononuclear phagocyte stimulation
05/15/2003US20030091509 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
05/15/2003US20030091506 Methods of using 22417, a novel human aminoprotease family member
1 ... 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 ... 3163